ENTA icon

Enanta Pharmaceuticals

122 hedge funds and large institutions have $454M invested in Enanta Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 45 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

3% less funds holding

Funds holding: 126122 (-4)

16% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 45

24% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 17

Holders
122
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.29M
Puts
$1.05M
Net Calls
Net Calls Change

Top Sellers

1 -$8.07M
2 -$3.6M
3 -$3.53M
4
BlackRock
BlackRock
New York
-$3.48M
5
MCM
Matarin Capital Management
New York
-$2.56M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$79.1M
2
$39.8M
3
$33.6M
4
$30.5M
5
$24.7M
6
$22.3M
7
$20M
8
$17.7M
9
$17.5M
10
$11.2M
11
$9.96M
12
$9.89M
13
$9.5M
14
$7.2M
15
$7.04M
16
$6.91M
17
$5.46M
18
$5M
19
$4.96M
20
$4.91M
21
$4.19M
22
$3.82M
23
$3.6M
24
$3.27M
25
$3.01M